Terms: = Bone cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
7 results:
1. Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Gerratana L; Davis AA; Velimirovic M; Clifton K; Hensing WL; Shah AN; Dai CS; Reduzzi C; D'Amico P; Wehbe F; Medford A; Wander SA; Gradishar WJ; Behdad A; Puglisi F; Ma CX; Bardia A; Cristofanilli M
Breast Cancer Res; 2023 Oct; 25(1):112. PubMed ID: 37784176
[TBL] [Abstract] [Full Text] [Related]
2. A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma.
Zhao Y; Gao J; Fan Y; Xu H; Wang Y; Yao P
BMC Musculoskelet Disord; 2023 Jun; 24(1):519. PubMed ID: 37353812
[TBL] [Abstract] [Full Text] [Related]
3. TRIM22 inhibits osteosarcoma progression through destabilizing nrf2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract] [Full Text] [Related]
4. C3a and C5a facilitates the metastasis of myeloma cells by activating nrf2.
Xiong J; Kuang X; Lu T; Yu K; Liu X; Zhang Z; Wang W; Zhao L; Fang Q; Wu D; Wang J
Cancer Gene Ther; 2021 Apr; 28(3-4):265-278. PubMed ID: 32873871
[TBL] [Abstract] [Full Text] [Related]
5. BMP8A promotes survival and drug resistance via nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma.
Yu YP; Cai LC; Wang XY; Cheng SY; Zhang DM; Jian WG; Wang TD; Yang JK; Yang KB; Zhang C
Cancer Sci; 2020 May; 111(5):1555-1566. PubMed ID: 32128917
[TBL] [Abstract] [Full Text] [Related]
6. Expression of the nrf2 and Keap1 proteins and their clinical significance in osteosarcoma.
Zhang J; Wang X; Wu W; Dang H; Wang B
Biochem Biophys Res Commun; 2016 Apr; 473(1):42-46. PubMed ID: 26987716
[TBL] [Abstract] [Full Text] [Related]
7. nrf2 expression is associated with poor outcome in osteosarcoma.
Park JY; Kim YW; Park YK
Pathology; 2012 Dec; 44(7):617-21. PubMed ID: 23172081
[TBL] [Abstract] [Full Text] [Related]
